ACA
HOLX

American Capital Advisory’s Hologic HOLX Stock Holding History

American Capital Advisory’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8
Closed -$605 – 1195
2026
Q1 		$605 Sell
8
-80
-91% -$6.01K ﹤0.01% 805
2025
Q4 		$6.56K Hold
88
– – ﹤0.01% 353
2025
Q3 		$5.94K Buy
88
+3
+4% +$199 ﹤0.01% 345
2025
Q2 		$5.54K Buy
85
+5
+6% +$300 ﹤0.01% 338
2025
Q1 		$4.94K Hold
80
– – ﹤0.01% 338
2024
Q4 		$5.77K Hold
80
– – ﹤0.01% 338
2024
Q3 		$6.52K Hold
80
– – ﹤0.01% 326
2024
Q2 		$5.72K Hold
80
– – ﹤0.01% 295
2024
Q1 		$6.46K Hold
80
– – 0.01% 289
2023
Q4 		$5.72K Buy
+80
New +$5.57K ﹤0.01% 295

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

American Capital Advisory's HOLX Position: Q2 2026 in Review

American Capital Advisory sold out of Hologic (HOLX) in Q2 2026, closing a stake of 8 shares — an estimated $605 sold.

American Capital Advisory first reported a position in HOLX in Q4 2023 and held it in 10 quarters. The position peaked at $6.56K in Q4 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • American Capital Advisory reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • American Capital Advisory sold 8 Hologic shares in Q2 2026, an estimated $605.
  • American Capital Advisory first reported a position in Hologic in Q4 2023 and held it in 10 quarters.
  • American Capital Advisory's Hologic position peaked at $6.56K in Q4 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.